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ABSTRACT
Triple-negative breast cancer (TNBC) is a highly aggressive and
recurrent type of breast carcinoma that is associated with poor patient
prognosis. Because of the limited efficacy of current treatments, new
therapeutic strategies need to be developed. The CXCR4-CXCL12
chemokine signaling axis guides cell migration in physiological and
pathological processes, including breast cancermetastasis. Although
targeted therapies to inhibit the CXCR4-CXCL12 axis are under
clinical experimentation, still no effective therapeutic approaches
have been established to block CXCR4 in TNBC. To unravel the role
of the CXCR4-CXCL12 axis in the formation of TNBC early
metastases, we used the zebrafish xenograft model. Importantly,
we demonstrate that cross-communication between the zebrafish and
human ligands and receptors takes place and human tumor cells
expressing CXCR4 initiate early metastatic events by sensing
zebrafish cognate ligands at the metastatic site. Taking advantage
of the conserved intercommunication between human tumor cells and
the zebrafish host, we blocked TNBC early metastatic events by
chemical and genetic inhibition of CXCR4 signaling. We used IT1t, a
potent CXCR4 antagonist, and show for the first time its promising
anti-tumor effects. In conclusion, we confirm the validity of the
zebrafish as a xenotransplantation model and propose a
pharmacological approach to target CXCR4 in TNBC.
KEY WORDS: CXCR4, CXCL12, IT1t, Triple-negative breast cancer,
Metastases, Inter-species crosstalk, Xenograft, Zebrafish
INTRODUCTION
CXCR4 is a chemokine receptor, first described in the early 1990s
(Baggiolini et al., 1997;Herzog et al., 1993; Jazin et al., 1993;Nomura
et al., 1993) and identified as a co-receptor for human
immunodeficiency virus (HIV) entry (Feng et al., 1996). It is a
seven-transmembraneG-protein-coupled receptor with amajor role in
physiological processes such as hematopoiesis (Nagasawa et al., 1996;
Rosu-Myles et al., 2000), leukocyte trafficking (Day and Link, 2012;
Sallusto andBaggiolini, 2008; Sallusto et al., 2000), cellmigration and
organogenesis during ontogeny (Bussmann andRaz, 2015), as well as
pathological conditions like HIV pathogenesis (Vicenzi et al., 2013),
WHIM syndrome (warts, hypogammaglobulinemia, infections and
myelokathexis syndrome) (Gulino, 2003) and cancer (Balkwill, 2004;
Chatterjee et al., 2014). Its cognate ligand is the homeostatic cytokine
CXCL12 (Bleul et al., 1996; Oberlin et al., 1996) [also known as
stromal cell-derived factor 1 (SDF-1)]. However, recent reports
indicate that ubiquitin and macrophage migration inhibitory factor
(MIF) can also bind to and signal through CXCR4 (Saini et al., 2010;
Bernhagen et al., 2007; Saini et al., 2011; Pawig et al., 2015). Upon
CXCL12 binding, CXCR4 triggers cell migration, proliferation and
transcriptional control of downstream targets via G-protein-dependent
or -independent mechanisms (Pawig et al., 2015). Dissociation of Gα
and Gβγ subunits leads to Ca2+ release and activation of the PI3K/
AKT and MAPK signaling pathways (Teicher and Fricker, 2010).
CXCR4 dimerization occurs after ligand binding; subsequently,
phosphorylation by JAK kinases takes place, followed by STAT
signaling initiation in a G-protein-independent mechanism (Mellado
et al., 2001; Vila-Coro et al., 1999). Moreover, initiation of β-arrestin
signaling can take place, resulting in G-protein coupled receptor
(GPCR) signaling blockade (Lefkowitz, 1998; Shukla et al., 2011)
or ERK1/2 activation (Luttrell et al., 1999). CXCR4 activity is
regulated by mechanisms of desensitization, through phosphorylation
of the C-terminus and internalization, which is followed by
degradation or recycling to the plasma membrane (Busillo and
Benovic, 2007). Moreover, CXCL12 binds also to CXCR7
(Balabanian et al., 2005). However, differently from other
chemokine receptors, CXCR7 does not signal through G proteins
and acts as a ligand scavenger in a β-arrestin-mediated pathway
(Rajagopal et al., 2010). Interestingly, a key role of the CXCL12-
CXCR4-CXCR7 axis in collective tissue migration has been studied
in zebrafish embryos. In the migration of the lateral line primordium,
Cxcl12 scavenging byCxcr7 leads to the formation of a self-generated
gradient and cell migration after Cxcr4 activation, along tissues where
Cxcl12 is homogeneously distributed (Boldajipour et al., 2008; Dona
et al., 2013; Venkiteswaran et al., 2013).
A link between CXCR4 and cancer, in particular metastatic breast
cancer, has been reported (Muller et al., 2001). CXCR4-expressing
tumor cells preferentially colonize distant organs that secrete high
levels of CXCL12, such as brain, lungs, lymph nodes, liver and
bone marrow (Janowski, 2009). Among highly aggressive
malignancies of the breast, triple-negative breast cancer (TNBC)
is often associated with relapse and poor patient prognosis (PalmaReceived 11 September 2015; Accepted 25 December 2015
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et al., 2015; Podo et al., 2010). Conventional hormone-based
therapies are not applicable owing to the absence of expression of
the estrogen and progesterone receptors, and Her2 gene
amplification (Anders and Carey, 2009). Accordingly, surgery
and chemotherapy are the main form of medical intervention and no
targeted therapies are currently available (Wahba and El-Hadaad,
2015). Therefore, a better understanding of the biology of this
aggressive breast carcinoma and the development of new therapies
to reduce the high mortality rate are urgently needed. The bicyclam
AMD3100, also known as plerixafor, is a CXCR4 antagonist and
has been introduced in clinical trials to treat different tumor types,
mainly leukemia and lymphomas (Ramsey and McAlpine, 2013).
However, it has been reported to cause cardiotoxicity (Hendrix
et al., 2004). AMD3100 also functions as an agonist for CXCR7
(Kalatskaya et al., 2009), which has been linked to breast cancer cell
proliferation (Salazar et al., 2014). In addition, an anti-CXCR4
antibody is currently in clinical trials (Kuhne et al., 2013; Vela et al.,
2015). More CXCR4 antagonists have been developed and in vitro
as well as animal models are required to further explore clinical
applications in patients.
Zebrafish is increasingly being used as an animal model for
translational research in oncology (Amatruda et al., 2002; Barriuso
et al., 2015; Ghotra et al., 2015). In particular, transparent
zebrafish embryos allow following the behavior of fluorescent
tumor cells in a living organism. Human cancer cells engrafted in
the blood circulation of 2-day-old transgenic embryos, with
fluorescently traceable endothelial (Lawson and Weinstein, 2002)
and immune cells (Ellett et al., 2011; Renshaw et al., 2006), have
been described to induce angiogenesis and form micrometastases
in concert with immune cell interaction (He et al., 2012). Tumor
angiogenesis and colonization of secondary tissues can be
visualized in a short time period (2-6 days) in the small and
fast-developing larvae. Although numerous discoveries have been
made using zebrafish embryos as a xenotransplantation model,
lack of knowledge about the communication between human
and zebrafish cells has questioned its validity and partially limited
its use.
Here, we report that the CXCR4-CXCL12 axis acts across
zebrafish and humans and drives the formation of tumor
micrometastases of human TNBC cells in zebrafish. Cell
treatment with IT1t, a potent CXCR4 antagonist, and genetic
silencing of CXCR4 effectively inhibited early metastatic events in
vivo. Therefore, using zebrafish as a xenotransplantation model, we
propose a potential treatment to impair CXCR4 signaling and
reduce the metastatic onset of TNBC.
RESULTS
TNBC cells display high CXCR4 expression levels and
increased metastatic behavior in a zebrafish
xenotransplantation model
We first characterized the expression profile of CXCR4 andCXCR7,
both chemokine receptors for CXCL12, in the TNBC line MDA-
MB-231-B. Because this cell line derives from bone metastases of
MDA-MB-231, after repeated engraftments into a murine host
(Wetterwald et al., 2002), we used the parental line as a reference.
We found that, compared to the original TNBC line, derived from
human pleural metastases, the bone clone expressed higher CXCR4
and lower CXCR7 mRNA levels (Fig. 1A,B). Moreover, when
compared in vitro, MDA-MB-231-B displayed a higher
proliferation rate than the parental line (data not shown). To
determine whether TNBC cells with increased CXCR4 expression
displayed a different behavior, we engrafted both MDA-MB-231
and MDA-MB-231-B in zebrafish. As previously reported (He
et al., 2012), tumor cells were inoculated in the blood circulation of
2-days post-fertilization (dpf ) embryos via the duct of Cuvier, a vein
plexus that opens into the heart (Fig. 1C,C′). Fluorescent tumor cells
derived from both cell lines entered the blood vessels and, at 5 hours
post-injection (hpi), they were mainly found in the tail and trunk
vessels of the Tg(kdrl:EGFP)s843 zebrafish reporter line with green
fluorescent vasculature (Fig. 1D,E). Injected embryos were
examined by microscopy and embryos with 25-50 tumor cells
hematogenously disseminating into the dorsal aorta (DA), caudal
vein (CV) and vessel branches of the caudal hematopoietic tissue
(CHT), in the region between the urogenital opening and the end of
the tail, were selected for the experiment. Tumor cells spread
through the embryo via blood circulation of the head, trunk and tail.
Intravascular and perivascular cancer cells were found in the basilar
artery (BA), branchial arches (BAs) and optic vessels in the head
region (Fig. 1F-H), and in intersegmental vessels (ISVs), dorsal
longitudinal anastomotic vessels (DLAVs) and the DA and CV in
both the trunk and tail areas (Fig. 1I,J). Moreover, tumor cells were
often positioned near vessel branching points (Fig. 1I), as to follow a
path in a similar fashion to nascent lymphatic vessels, known to
express cxcr4a/b receptors (Cha et al., 2012). Interestingly, cxcl12a
and cxcl12b are expressed at these sites in developing zebrafish
embryos (Cha et al., 2012; Fujita et al., 2011; Hess and Boehm,
2012). Highly aggressive cancer cells, adhering to the intravascular
endothelium, initiated early metastatic events in the tail, sustaining
tumor progression until 4-days post-implantation (dpi). In our
model, in which tumor cells are inoculated directly into the blood
circulation to study the formation of experimental micrometastases,
bypassing initial modifications in a primary tumor mass, early
metastatic events coincided with tumor foci formation and
expansion, tumor extravasation, with adherence to the
extravascular endothelium, and invasion. In line with previous
work from our group, the tail fin region, in proximity of the CHT, a
temporary site of hematopoiesis analogous to the fetal liver in
mammalian development, was a preferential early metastatic site
(He et al., 2012).
After reaching the vascular plexus that infiltrates the CHT, MDA-
MB-231 and MDA-MB-231-B displayed divergent phenotypes.
From 1 until 4 dpi, the parental line MDA-MB-231 showed a
weakened behavior over time (Fig. 1K-M,K′-M′), whereas the bone
clone induced increasingly aggressive phenotypes (Fig. 1N-P,N′-P′).
The formation of a secondary tumor mass began at 1 dpi and was
observed in 88% of the embryos engrafted with MDA-MB-231-B
(n>40) (Fig. 1N,N′). In theMDA-MB-231 group, secondary tumors
could be observed in 33.3% of the embryos (n>40) (Fig. 1K,K′).
MDA-MB-231-B cells, with higher CXCR4 expression, were found
to progressively extravasate (from 21.4% at 1 dpi to 100% at 4 dpi),
as well as to increasingly invade the surrounding tissue of the tail
(from 4.7% at 1 dpi to 94% at 4 dpi) (Fig. 1N-P,N′-P′). Invasive
cells were distinguished from extravasating cells once they were no
longer in contact with the external wall of the endothelium and
localized in the surrounding tail fin tissue (Fig. 1O′,P′). On the other
hand, the MDA-MB-231 line, with lower CXCR4 mRNA levels,
displayedmaximum extravasation at 2 dpi (20.4%), with a reduction
at 4 dpi (16%). Invasive events were detected at 2 dpi (4.5%),
whereas no invading cells were found in the tail fin at 4 dpi
(Fig. 1M,M′). In conclusion, formation of a compact tumor
structure, cancer cell extravasation, and invasion of the CHT and
tail fin tissues increased over time in MDA-MB-231-B and
decreased in MDA-MB-231. Taken together, our data show that
the TNBC cell line MDA-MB-231-B displays high CXCR4
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Fig. 1. CXCR4 expression levels correlate with metastatic potential in a zebrafish xenotransplantation model. The bone clone (MDA-MB-231-B)
expressed higher levels of CXCR4mRNA (A) and lower levels of CXCR7mRNA (B), compared to the parental cell line MDA-MB-231, originated from metastatic
triple-negative breast cancer (TNBC) [unpaired t-test, (A) **P=0.0016, (B) **P=0.0019]. Upon engraftment into the duct of Cuvier (C,C′ red arrow) of 2-dpf
zebrafish embryos (C′), MDA-MB-231 circulated in the vascular system (D), in a comparablemanner to MDA-MB-231-B (E). Arrowhead in C represents the site of
injection. CHT, caudal hematopoietic tissue. (F-J) Tumor cells disseminated throughout the embryo, in the head (F-H), the eye (H), the trunk and the tail (I,J), and
extended filopodia at vessel branching points (I, arrowhead). BA, basilar artery; BAs, branchial arches; CV, caudal vein; DA, dorsal aorta; DLAV, dorsal
longitudinal anastomotic vessel; ISV, intersegmental vessel. (K-P′) Over time, a weaker phenotype was detectable for the MDA-MB-231 cell line (K-M,K′-M′),
whereas evident secondary tumor mass formation, extravasation and tail fin invasion persisted when MDA-MB-231-B cells were implanted (N-P,N′-P′). Arrows in
O′ and P′ indicate invasive cancer cells that are not in contact with the endothelium and are found in the tail fin tissue, after extravasation. Images were
acquired using a Leica TCSSPE confocal microscopewith an HCPL FLUOTAR 10×DRYobjective (0.30 N.A.) in panel C andwith an HCAPO20×DRYobjective
(0.7 N.A.) in panel H. All other images were acquired using a Leica MZ16FA fluorescent microscope coupled to a DFC420C camera. Scale bars: 50 µm.
Phenotype assessment was carried out at 1, 2 and 4 dpi, evaluating the ability of both cell lines to form a secondary tumor mass, to extravasate and to invade the
surrounding tail fin. Images are representative of embryos injected with MDA-MB-231 and number of individuals was n=51 (5 hpi) (D), 45 (1 dpi) (K), 44 (2 dpi) (L)
and 25 (4 dpi) (M) or with MDA-MB-231-B and number of individuals was n=44 (5 hpi) (E), 42 (1 dpi) (N), 36 (2 dpi) (O) and 34 (4 dpi) (P). Percentages relative to
tumor mass (TM), tumor extravasation (TE) and tumor invasion (TI) are reported for each stage, for both MDA-MB-231 and MDA-MB-231-B cell lines.
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expression and enhanced metastatic behavior in the zebrafish
embryo.
The CXCR4-CXCL12 signaling axis is cross-activated in
zebrafish and humans
Cancer cells expressing CXCR4 form distant metastases in
secondary organs that produce high levels of CXCL12, in human
specimens and murine models (Muller et al., 2001). Our initial
findings showed that TNBC cells initiating early metastatic events
in the zebrafish xenotransplantation model express high levels of
CXCR4. To establish whether CXCR4 sustained tumor metastatic
properties in a Cxcl12-dependent manner, we first assessed
whether the CXCR4-CXCL12 axis acts across zebrafish and
human. Two cxcl12 genes, cxcl12a and cxcl12b, are found in
zebrafish, following duplication events during teleost evolution. In
a multiple alignment (Fig. 2A), human CXCL12 (α-isoform)
shared 47.73% identical residues with both zebrafish Cxcl12a and
Cxcl12b, whereas 75.26 was the percentage of identity between
zebrafish Cxcl12 paralogs. Pair-wise sequence alignment showed
59% identity on residues involved in receptor binding, when the
Fig. 2. Zebrafish Cxcl12 ligands activate CXCR4 signaling in human cancer cells. Human CXCL12 was aligned to the zebrafish homologs using
ClustalW (A). Amino acid residues were conserved in the receptor binding region and activation motif of CXCL12/Cxcl12 chemokines (A,B). Asterisks (*)
represent fully conserved residues; colons (:) and periods (.) indicate positions at which residues share strong or weak similarity, respectively. (C,D) Human
CXCL12-α and zebrafish ligandsCxcl12a andCxcl12b induced calcium flux inMDA-MB-231-B cells, as detected by increased fluorescence intensity. The human
ligand initiated an immediate response that extinguished rapidly (31 s to register half fluorescence intensity after the highest response), whereas the zebrafish
ligands triggered a slower and prolonged signal induction (>55 s for zCxcl12a and >52 s for zCxcl12b to register half fluorescence intensity). (C) The fold intensity
increase is calculated by normalization on fluorescence intensity correspondent to signal before response activation. (D) Frames show intensity before signaling
activation was triggered by each ligand and at the highest peak of response. The time length to reach the strongest response is indicated.
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human ligand was compared to each zebrafish homolog, and
92.85% between Cxcl12a and Cxcl12b. Full identity in the
motif involved in receptor activation was found (Fig. 2B).
Therefore, considering the level of conservation, we verify that
the CXCR4 signaling on human tumor cells is activated by both
zebrafish Cxcl12 ligands. For this purpose, Ca2+ flux was
measured. Whereas human CXCL12 (100 nM) failed to induce
Ca2+ mobilization from intracellular storage into the cytoplasm in
the parental line MDA-MB-231 (Fig. S1), time-lapse microscopy
revealed that calcium sensor fluorescent signal intensity increased
when MDA-MB-231-B cells were stimulated with either the
human or the zebrafish ligands. In the bone clone, human CXCL12
elicited a response that increased and decreased rapidly. Zebrafish
Cxcl12a and Cxcl12b triggered a slower but still significant
response, in a non-synchronized fashion. In addition, the
fluorescent signal gradually faded and failed to extinguish at
once (Fig. 2C,D and Movies 1-3). Hence, we show that zebrafish
Cxcl12 ligands trigger CXCR4 signal activation in human TNBC
cells.
Next, we investigated whether human CXCL12 activates
zebrafish Cxcr4. As for the Cxcl12 ligands, two Cxcr4 receptors
have been described in zebrafish, Cxcr4a and Cxcr4b. ClustalW
(Goujon et al., 2010; Larkin et al., 2007) alignments of the human
CXCR4 with the zebrafish Cxcr4a and Cxcr4b (Fig. 3A) showed a
percentage of identity equal to 68 and 63.22 on whole sequence,
respectively (Fig. 3B). When ligand-binding regions were
considered, the pair-wise identity reached 48.6% (CXCR4-
Cxcr4a and CXCR4-Cxcr4b), whereas, in the dimerization
regions, 69.4% (CXCR4-Cxcr4a) and 55.5% (CXCR4-Cxcr4b)
of the residues were identical. Moreover, the signaling motif was
100% conserved (Fig. 3B). In addition, the zebrafish Cxcr4
paralogs displayed 74.15%, 60%, 66.6% and 100% identity at the
whole-sequence level, ligand-binding and receptor-dimerization
regions, and signalingmotif, respectively (Fig. 3B). Besides partial
redundancy, Cxcl12 and Cxcr4 zebrafish paralogs seemed to play
distinct functions and to have a different spatial expression during
embryo development, as reviewed (Bussmann and Raz, 2015).
In particular, cxcr4b is found to be expressed by myeloid
cells (Walters et al., 2010). To verify whether inter-species
crosstalk exists between human ligands and zebrafish receptors,
human recombinant CXCL12 (0.4 mg/ml) was injected in
the hindbrain ventricle (HBV) of 30-32 hours post-fertilization
Fig. 3. CXCR4 alignment shows similarity
between human and zebrafish proteins. Human
CXCR4 was aligned to the zebrafish homologs
using ClustalW (A). Asterisks (*) represent fully
conserved residues, colons (:) and periods (.)
indicate positions at which residues share strong or
weak similarity, respectively. The tyrosine (Y) in
brown belongs to both the signaling motif and
dimerization region. Amino acid residues were
conserved in the ligand-binding region, and
dimerization and signaling motifs in the CXCR4/
Cxcr4 receptors (B).
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(hpf ) Tg(mpeg1:mCherry)UMSF001 embryos, where macrophages
are fluorescently labeled (Fig. 4A). A 57% increase in the
number of cells that migrated to the site of injection was
observed compared to the mock-injected group, and in a similar
fashion to the zebrafish chemokine Cxcl11aa, previously shown to
be a chemoattractant for this class of phagocytes (Torraca et al.,
2015) (Fig. 4B,C). Furthermore, macrophage motility towards the
human CXCL12 (α-isoform) was found to be Cxcr4-dependent.
Macrophages did not respond to the human CXCL12 in the ody
mutant line, with a non-functional Cxcr4b receptor. Injection of the
human ligand in the HBV led to a 43% increase in macrophage
number compared to the water-injected group, in the wild-
type (wt) siblings, whereas no differences in mean cell number
was detected when CXCL12- and mock-injected groups were
compared in the odymutants (Fig. 4D,E). Moreover, we excluded a
possible Cxcr4b-dependent alteration of basal motility and total
macrophage number in ody mutants compared to wild-type
siblings (Fig. S2). In conclusion, zebrafish is a valuable in vivo
model to study human cancers, particularly focusing on the
interaction between cancer and host stromal cells, because human
attractants trigger zebrafish cell migration and zebrafish ligands are
sensed by human cells.
Zebrafish Cxcl12-sensing by human CXCR4 receptor
sustains TNBC cancer burden in zebrafish larvae
The tumor microenvironment plays a crucial role in the
establishment of a favorable niche for the onset of cancer
metastasis, and the CXCR4-CXCL12 axis, among other
signaling pathways, guides the communication between tumor
and microenvironment. We showed that crosstalk between human
Fig. 4. Human CXCL12 triggers zebrafish macrophage migration in a Cxcr4-dependent manner. (A) Scheme of a 30- to 32-hpf embryo and injection site
are shown. (B,C) Zebrafishmacrophages were found to be responsive to humanCXCL12 (0.4 mg/ml) 3 h after injection into the hindbrain ventricle (HBV) of 30- to
32-hpf embryos. No increase in macrophage number occurred when a mock solution (water) was inoculated. Zebrafish Cxcl11aa (1.5 mg/ml) was used
as a positive control (C). Data in C are pooled observations from two independent experiments (n=55 in mock; n=48 in hCXCL12; n=57 in zCxcl11aa).
(D,E) Macrophages were recruited by human CXCL12 in a Cxcr4-dependent manner: a higher number (43%) of L-P+/TSA− cells was found in the HBV compared
to the mock-injected group in wild-type (wt) siblings (D,E), whereas no differences were detected in the cxcr4b−/− (ody) mutants (E). In B, mCherry-expressing
macrophages are recruited by hCXCL12 as in D, where L-P staining combined to TSA detection is used to distinguishmacrophages (L-P+/TSA−) from neutrophils
(L-P+/TSA+). ****P<0.0001, nsP>0.05 one-way ANOVA, Bonferroni post-hoc test. Data in E are pooled observations from five independent experiments (n=171 in
mock/wt; n=180 in hCXCL12/wt; n=139 in mock/ody; n=160 in hCXCL12/ody).
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and zebrafish receptors and ligands (CXCR4/Cxcl12 and Cxcr4/
CXCL12) occurs in vitro and in the zebrafish embryo model.
Hence, we investigated whether CXCR4-expressing TNBC cells
initiated early metastatic events in vivo after sensing zebrafish
Cxcl12 ligands. MDA-MB-231-B cells were engrafted in the
blood circulation of zebrafish embryos carrying null mutations in
cxcl12a or cxcl12b. MDA-MB-231-B showed reduced localization
in the head (BA and BAs) and trunk (ISVs) in larvae with a
non-functional Cxcl12a (Fig. S3). However, tumor invasion
developed similarly in cxcl12a−/−/Tg(kdrl:EGFP)s843 larvae and
wt siblings at 4 dpi (Fig. 5A). The same effect was observed in the
cxcl12b−/−/Tg(kdrl:EGFP)s843 mutants and wt siblings at 2 and
4 dpi (Fig. S4A). Like tumor invasion, also the overall
micrometastasis burden in the tail fin was the same in wt,
cxcl12a−/−/Tg(kdrl:EGFP)s843 and cxcl12b−/−/Tg(kdrl:EGFP)s843
at 2 dpi (Fig. S4B,C). However, the response of tumor cells in the
Ca2+ assay to both zebrafish Cxcl12a and Cxcl12b supports
the hypothesis that human tumor cells sense the Cxcl12a ligand in
a cxcl12b mutant and the Cxcl12b ligand in a cxcl12a mutant.
Therefore, in this scenario, tumor invasion and tumor burden could
still occur in each single-ligand mutant line. Hence, the xenogeneic
implantation was performed in the cxcl12a−/−/cxc12b−/−/Tg(kdrl:
EGFP)s843 double-mutant embryos. For this purpose, the
cxcl12a−/−/cxc12b+/−/Tg(kdrl:EGFP)s843 family was in-crossed
and tumor engraftments were performed in the siblings of the F1
generation (experimental groups were blinded). Tumor burden
and tumor invasion were significantly decreased in the double
mutants compared to cxcl12a−/−/cxc12b+/−/ Tg(kdrl:EGFP)s843
and cxcl12a−/−/cxc12b+/+/Tg(kdrl:EGFP)s843 siblings at 4 dpi
(Fig. 5B,C and D,E, top panels). Mutant larvae for both ligands
were distinguished from the siblings by screening for abnormal
formation of the hypobranchial arteries at 6 dpf (Fig. 5D,E,
bottom panels). Therefore, we suggest that the CXCR4-CXCL12
axis functions in a paracrine fashion across species and is
responsible for driving the formation of TNBC micrometastases
in zebrafish. Importantly, a potential role of the human CXCL12
Fig. 5. CXCR4-expressing TNBC cells fail to initiate metastatic events in cxcl12a- and cxcl12b-null zebrafish mutants. (A) No differences in tumor
cell invasion were found in themedusa (cxcl12a−/−) mutants, compared towild-type (wt) siblings. (B,C) Breast cancer cells failed to formmicrometastases in 4-dpi
zebrafish embryos deficient for both cxcl12a and cxcl12b ligands, whereas tumor invasion (B) and tumor burden (C) occurred in the cxcl12a−/−/cxcl12b+/+ and
cxcl12a−/−/cxcl12b+/− siblings. Unpaired t-test: (A) ns, P>0.05 (wt: n=73; medusa: n=66), (B) **P=0.0012 and (C) **P=0.0033 (n=11 in each group). Graphs in
A-C are cumulative of two independent experiments. (D,E) Top panels: MDA-MB-231-B breast cancer cells were highly invasive in the siblings, whereas few
tumor cells remained in the metastatic region in zebrafish that were mutant for both ligands. Images were acquired using a Leica MZ16FA fluorescent microscope
coupled to a DFC420C camera. Bottom panels: vessel connections are compared to distinguish siblings and double mutants: the hypobranchial arteries (HA),
indicated by asterisks, failed to connect to the mandibular arch (AA1) in the cxcl12a−/−/cxcl12b−/− larvae. Images were acquired using a Leica TCS SPE confocal
microscope with an HC PL FLUOTAR 10× DRY objective (0.30 N.A.). Scale bars: 50 µm. (F) CXCL12 expression is lower in the MDA-MB-231-B compared
to MCF-7 breast cancer cell line. Unpaired t-test, with Welch’s correction. **P=0.006. qPCR was performed on two biological replicates.
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autocrine loop in driving the formation of TNBC micrometastases
in vivo is unlikely. CXCL12 expression levels were undetectable
in the parental line MDA-MB-231 (data not shown) and
significantly lower in MDA-MB-231-B compared to the
Luminal A (ER+, PR+/−, Her2−) MCF-7 breast cancer cell line
(Fig. 5F). Accordingly, a very low expression of CXCL12 in
MDA-MB-231-B argued against the generation of a potential
autocrine loop to activate the receptor CXCR4. Taken together,
Fig. 6. The CXCR4 antagonist IT1t reduces metastatic tumor burden in vivo. IT1t (20 µM) was applied into the cell medium for 24 h prior to engraftment in
zebrafish embryos to antagonize CXCR4 receptor activation (A). The percentage of live cells after treatment was not significantly different than in the control
condition (three independent experiments) (B). The metabolic activity, readout of cell growth, was not significantly affected when increasing concentrations of
IT1t were used (C). Pre-treatment in vitro caused a reduction in tumor burden at the secondary site in vivo, both at 2 dpi (D) and 4 dpi (E). Cancer cell burden
increased over time from 2 to 4 dpi in the control group, whereas it remained at comparable levels upon treatment (F). Data set in F is obtained by using the same
data points as shown in D and E. Number of larvae is n=64 (DMSO) and n=75 (IT1t) at 2 dpi and n=59 (DMSO) and n=56 (IT1t) at 4 dpi. (G) Effect of CXCR4
inhibition on tumor burden over time is shown. Scale bars: 50 µm. Data are mean±s.e.m. from two independent experiments. Statistical analysis: two-tailed,
unpaired t-test and ANOVA with Bonferroni post-hoc test for datasets with two or more groups respectively. ****P<0.0001; **P=0.005; ns, P>0.05.
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the onset of early metastatic events in this experimental system
is enhanced by the CXCR4-CXCL12 axis in a zebrafish
xenotransplantation model in which human tumor cells respond
to zebrafish ligands.
The CXCR4 antagonist IT1t reduces the formation of TNBC
early metastases in vivo
The use of CXCR4 antagonists as a therapeutic targeted approach to
inhibit tumor spreading and the formation of metastases has been
introduced in clinical trials for different cancer types. Despite the
fact that CXCR4 is highly involved in the establishment of
secondary neoplasias, there are no approved FDA drugs to block
CXCR4 in TNBC. In the zebrafish xenograft model in which
CXCR4-Cxcl12 inter-species communication supports TNBC early
metastasis onset, we test whether the isothiourea derivative IT1t,
a recently described CXCR4 antagonist (Thoma et al., 2008),
displays anti-neoplastic functions. This small molecule is an
orthosteric competitor of the CXCL12 N-terminal signaling
peptide and it impairs signaling activation by interfering with the
docking of the ligand domain to the receptor (Wu et al., 2010).
MDA-MB-231-B cells were treated in vitro for 24 h and
subsequently engrafted in zebrafish embryos. Cells proliferated in
treated (20 μM) and untreated conditions (Fig. 6A). Cell survival
was not significantly changed: the percentage of live cells was
found to be comparable in both groups (97% DMSO, 92% IT1t)
(Fig. 6B). To monitor cell viability, a WST-1 (tetrazolium salt)
proliferation assay was performed. After a 24 h incubation period
with increasing concentrations of IT1t (5, 10 and 20 µM), cancer
cell metabolic activity was not changed when compared to vehicle
control (Fig. 6C). After pre-treatment (20 µM), engraftment of cells
in the blood circulation of 2-dpf zebrafish embryos was performed
and tumor burden assessed at the metastatic site at 2 and 4 dpi
(Fig. 6D-G). CXCR4 chemical inhibition affected tumor burden,
with a 39.5% and 60% reduction at 2 and 4 dpi, respectively
(Fig. 6D,E). An increase in tumor burden was found from 2 to 4 dpi
for MDA-231-B pre-treated with DMSO, whereas no difference
was detected in the IT1t group (Fig. 6F). At 2 dpi, TNBC cells
associated to form a secondary mass inside the CV and invaded the
tail fin, forming micrometastases at 4 dpi (Fig. 6G, top panel).
Blocking CXCR4 in vitro impaired tumor mass formation in vivo:
few cells remained in the CV at 2 dpi and consequently minor
invasive events occurred at 4 dpi (Fig. 6G, bottom panel). To
phenocopy the suppressive effect of CXCR4 pharmacological
inhibition on tumor aggressiveness, we used RNA interference.
Stable CXCR4 knockdown was achieved via lentiviral transduction
of two independent CXCR4 short hairpin RNAs (shRNAs). We
confirmed CXCR4 silencing on a gene expression level, via
quantitative PCR (qPCR). Notably, CXCR4 mRNA levels were
decreased in sh#1 and sh#2 compared to scrambled control shRNA,
showing a knockdown efficiency of 66% and 80%, respectively
(Fig. 7A). Subsequently, xenograft experiments were performed.
Tumor cell invasion at the metastatic site was effectively reduced
upon CXCR4 silencing (Fig. 7B), similar to the antagonist IT1t
(Fig. 7C). Therefore, using chemical and genetic approaches, we
demonstrate that CXCR4 signaling inhibition reduces the formation
of TNBC early metastases in vivo and describe IT1t as a potential
therapeutic for metastatic TNBC.
DISCUSSION
Metastatic TNBC is a major challenge for biopharmaceutical and
clinical research because tumor relapse and cell spreading represent
the main cause of death for patients. The development of targeted
therapies, in combination with conventional chemotherapy, is an
important approach to prolong patient lifetime. Although steps
forward in elucidating cancer dissemination have been made,
generally the pathogenesis of metastases is not fully understood.
Monitoring single tumor cells while crossing the blood vessel
boundaries in vivo is an optimal scenario to unravel early metastatic
events. For this purpose, zebrafish is an advantageous model. The
transparency of the embryos and the use of reporter lines make the
zebrafish an excellent host to study human tumor cell growth and
invasion at early stages (Movie 4). In the last decade the zebrafish
xenotransplantation model has been used to study human tumor
progression (Konantz et al., 2012) and to discover potential
treatments (van der Ent et al., 2014a,b; Veinotte et al., 2014; Zoni
et al., 2015). However, the translational validity of a zebrafish
xenotransplantation approach has been questioned. Concerns have
emerged on possible inter-species crosstalk and lack of species-
specific environmental cues. Here, we show that the cross
communication between human tumor cells and zebrafish ligands
is maintained, because zebrafish Cxcl12 activates human CXCR4
signaling in vitro and supports the formation of TNBC early
metastases in vivo. We found that TNBC cells with high CXCR4
expression levels exhibit aggressive features in zebrafish, in
agreement with findings in patients and other models. In addition
to CXCR4 and CXCR7 mRNA levels, other differences in gene
expression between MDA-MB-231-B and MDA-MB-231 might be
present and influence tumor cell behavior. Notably, we proved that
CXCR4-linked tumor burden occurred in a zebrafish Cxcl12-
dependent manner. The involvement of the human CXCL12 ligand
Fig. 7. CXCR4 genetic impairment via RNA interference recapitulates chemical treatment effects on early metastatic events. (A) CXCR4 stable
knockdown efficiency obtained via shRNAwas 66% and 80% for the shRNA #1 (sh#1) and sh#2, respectively. A reduced tumor cell invasion was observed in cell
lines carrying one of theCXCR4 targeting shRNAs (B) as well as upon pre-treatment before engraftment with the CXCR4 antagonist (C). (A,B) One-way ANOVA
with Bonferroni post-hoc test: ****P<0.0001, ***P=0.0002, **P<0.01. (C) Un-paired t-test: ****P<0.0001.
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is questioned owing to very low expression levels, in line with the
evidence that CXCL12 expression is higher in non-metastatic breast
tumors, compared to metastatic ones (Zhao et al., 2014). However,
CXCR4 activation by autocrine mechanisms cannot be fully
excluded and CXCL12 knockdown is required to completely rule
out this possibility. Moreover, Cxcr4-expressing macrophages
migrate towards human CXCL12, demonstrating that the
intercommunication takes place in both directions and confirming
the validity of the zebrafish embryo model to study human tumors.
Using the zebrafish xenograft model, we observed that TNBC cells
make contact with the endothelium, after inoculation in the blood
circulation. Then, tumor-endothelium interaction favors tumor mass
formation and, consequently, tumor extravasation and invasion.
Interestingly, the invasive process frequently recurs when tumormass
formation and growth are observed at earlier stages, whereas a
minimized or absent invasion takes place if no tumor mass is present.
This scenario is in accordance with the hypothesis, proposed by
Ewing in 1929 (Ewing, 1929), that there is a link between metastasis
and organization of the vascular system, stressing the mechanical
nature of cancer homing to different sites in the body. At the same
time, we could not observe tumor aggregates and invasion
phenomena in other tissues along the trunk that are also perfused
by the DA and the CV in the zebrafish larvae. The aggressive tumor
phenotype occurred mainly in the CHT, a site of hematopoiesis in
zebrafish larvae. This is in line with the frequent presence of TNBC
metastases in the bone marrow of adult mammals (Shi et al., 2014)
and correlates with Cxcl12 ligand expression in zebrafish. In the
zebrafish tail region, cxcl12a is generally expressed in the CHT
(Walters et al., 2010), and expression of cxcl12a and cxcl12b is
normally found in the endothelium of the CV and DA, respectively
(Cha et al., 2012). Perhaps bothCxcl12a andCxcl12bwork in concert
in sustaining tumor adhesion to the endothelium and consequent
tumor burden. Using the zebrafish model, we propose that receptor
activation via ligand stimulation and not necessarily in response to a
Cxcl12 gradient enhance tumor burden and subsequent invasion.
This observation is in linewith the ‘seed and soil’ theory proposed by
Paget in 1889 (Paget, 1989): tumor cells, the ‘seed’, form a secondary
mass in a growth-supportive microenvironment or ‘fertile soil’.
Moreover, the preferential growth and invasion in the CHT partially
explain why the bone clone and not the parental line MDA-MB-231,
more commonly used in other animal models, showed aggressive
features in the zebrafish embryo. In conclusion, our data are in
agreement with previous theories (Fidler, 2003) that both mechanical
and microenvironment-related factors contribute to tumor mass
formation and cell invasion to ultimately initiate the metastatic
process.
Attempts in the clinic have been made to pharmaceutically
interfere with CXCR4-CXCL12 signaling. AMD3100 (plerixafor),
the most commonly used drug to inhibit the receptor CXCR4, is
currently in clinical trials for glioma, leukemia, Ewing sarcoma,
neuroblastoma and brain tumors and is already FDA-approved for
Non-Hodgkin’s lymphomas and multiple myeloma. However,
long-term secondary effects and mobilization of hematopoietic
stem cells have been registered. Alternatively, CXCL12 targeting
agents are currently in clinical trials and under investigation (Scala,
2015). IT1t is an orally available isothiourea compound that
antagonizes CXCR4 activation with high specificity and potency, as
shown in the Ca2+ flux assay, inhibition of X4-HIV attachment and
whole-blood actin polymerization assay in rats (Thoma et al., 2008).
Moreover, residues involved in IT1t binding to CXCR4 are not
conserved in CXCR7 (Yoshikawa et al., 2013). We showed for the
first time that CXCR4 inhibition via IT1t results in a reduction of
early metastasis formation in vivo. A reduction in tumor invasion as
well as tumor mass formation was observed at 4 dpi in zebrafish
larvae, after 24 h pre-incubation in vitro. We propose that the
treatment affects ligand sensing in vivo, therefore affecting the
ability of tumor cells to survive in the blood circulation, colonize the
CHT, and to make contact with the endothelium to subsequently
proliferate and extravasate, initiating early metastatic events. Cancer
cell proliferation can occur inside blood vessels (Hanahan and
Weinberg, 2011) and extravasation events are linked to tumor-cell–
endothelium interaction (Stoletov et al., 2010). Moreover, highly
adherent tumor cells have been reported to have stem-cell-like
features (Bansal et al., 2014). Hence, it is not to be excluded that
TNBC cells that initiate early metastatic events in our model have
stem-like properties and might express high levels of CXCR4.
In conclusion, the zebrafish xenotransplantation model, in which
inter-species crosstalk is maintained, has provided new insight into
the metastatic events associated with TNBC and into the
employment of a potential compound to limit CXCR4-dependent
tumor early metastases.
MATERIALS AND METHODS
Zebrafish husbandry
Zebrafish lines were maintained according to standard protocols, described
in zfin.org, and handled in accordance with the Dutch animal welfare
regulations and the EU Animal Protection Directive 2010/63/EU.
Zebrafish lines
In the present study, the reporter lines Tg(kdrl:EGFP)s843 (Jin et al., 2005),
Tg(mpeg1:mCherry)UMSF001 (Bernut et al., 2014) and Tg(mpeg1:EGFP)gl22
(Ellett et al., 2011) were used to monitor tumor cell behavior, macrophage
recruitment and motility, respectively. Mutant lines used were cxcl12at30516
(medusa) (Valentin et al., 2007), cxc12bmu100 (Bussmann et al., 2011) and
cxcr4bt26035 [odysseus (ody)] (Knaut et al., 2003). cxcl12at30516/t30516
(cxcl12a−/−) and cxcr4bt26035/t26035 (cxcr4b−/−) mutants were identified,
before raising, for incomplete migration of the lateral line primordium at the
larval stage. Adult fins were clipped and DNA extraction for genotyping
was performed. Genotype identification was carried out using a KASP
assay. The following primers were used: A1 (reverse) 5′-CTGTGTTGAC-
TGTGGAACGGCAC-3′, A2 (reverse) 5′-CTGTGTTGACTGTGGAAC-
GGCAT-3′ and C1 (forward) 5′-AGCCAAGCCCATCAGCCTGGTA-3′
for cxcl12a; A1 (forward) 5′-GTGCTGGTGTCGCTCCACC-3′, A2
(forward) 5′-GTGCTGGTGTCGCTCCACG-3′ and C1 (reverse) 5′-AAC-
TTGATCTCTCGGATGCTCCGTT-3′ for cxcl12b; and A1 (reverse) 5′-
TGACGGTGGTCTTCAGTGCCTT-3′, A2 (reverse) 5′-TGACGGTGGT-
CTTCAGTGCCTA-3′ and C1 (forward) 5′-CAAGAACTCCAAGGGTC-
AGACTCTA-3′ for cxcr4b. KASP assay results were confirmed by
sequencing, using the following primers: 5′-AGGATGCTGTTCCGTTT-
TAC-3′ (forward) and 5′-TGTGTGTGTCTGACTAAGCA-3′ (reverse) for
cxcl12a; and 5′-AAGCCCATCAGTCTGGTGGAGAGG-3′ (forward)
and 5′-GTGCCCTTTGTCTGGTGTAACCTG-3′ (reverse) for cxcl12b.
Primers for cxcl12b−/− (Bussmann et al., 2011) and cxcr4b−/− (Miyasaka
et al., 2007) identification were previously described and used for
sequencing. For experiments, cxcl12a−/−/cxc12b+/−/Tg(kdrl:EGFP)s843
were in-crossed and double mutants were identified based on impaired
connection of the hypobranchial artery branches to the first aortic arch at
6 dpf. Cxcl12a−/− siblings, wild-type or heterozygote for cxcl12bmu100,
were considered as control groups.
Cell culture
The breast cancer cell line MDA-MB-231 [American Type Culture
Collection (ATCC)], the derived bone clone MDA-MB-231-B and MCF-
7 were cultured in DMEM complemented with 10% fetal calf serum (FCS)
and grown at 37°C and 5% CO2. pLenti-tdtomato plasmid was introduced
via lentiviral transduction in MDA-MB-231, whereas MDA-MB-231-B
cells stably expressed dsRed fluorescent protein. Blasticidin and G418 were
used to select cell clones that were tdtomato- or dsRed-positive, respectively.
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Cell lines were regularly tested for mycoplasma with the Universal
Mycoplasma Detection Kit (30-1012k, ATCC).
Proliferation assay
MDA-231-B tumor cells were treated with increasing concentrations (5, 10
and 20 μM) of CXCR4 antagonist IT1t (239821, Calbiochem) to assess cell
growth. A total of 30,000 cells were seeded in a singlewell of a 96-well plate.
The following day, inhibitor treatment was carried on for 24 h. WST-1
tetrazolium salt (05015944001, Roche) was added into the cell medium and
absorbance of the reduced by-product wasmeasured to quantify cell viability.
RNA interference
CXCR4 stable knockdown in MDA-MB-231-B was obtained using shRNA
containing constructs derived from Sigma MISSION library
[TRCN0000004054 (or #1): 5′-CTTTGTCATCACGCTTCCC-3′ and
TRCN0000004056 (or #2): 5′-GAATCACGTAAAGCTAGAA-3′].
Lentivirus virions were produced by transfecting HEK293T cells with
pKLO1-puro plasmid (containing the CXCR4-targeting shRNA or a non-
mammalian shRNA control), pCMV-VSV-G (envelope plasmid), pMDLg-
RRE (gag and pol elements) and pRSV-REV (rev or HIV1gp6) as
packaging vectors. Plasmid mix was added to cell medium together with
CaCl2 and incubated for 18-20 h. Virus-containing supernatant was
collected 48 and 72 h post-transfection and virus concentration was
measured using Lenti-X™ p24 Rapid Titer Kit (Clontech). For
transduction, MDA-MB-231-B cells were seeded in a 24-well plate
(25,000 cells/well) and lentiviruses [1-3 multiplicity of infection (MOI)]
added together with polybrene overnight (O.N.). Cells were cultured with
complete medium containing 1 µg/ml puromycin for four passages and
samples were collected for RNA isolation.
RNA isolation, cDNA synthesis and qPCR
RNA was isolated using a High Pure RNA Isolation Kit (Roche). After
DNAase treatment, complementary DNA (cDNA) synthesis was performed
(i-Script™ cDNA Synthesis Kit, Bio-Rad) and expression levels were
measured by qPCR (iQ™ SYBR®Green Supermix, Bio-Rad). Relative fold
changes of gene expression were calculated using the ΔΔCt method.CXCR4
primers (Fw: 5′-CAGCAGGTAGCAAAGTGACG-3′; Rv: 5′-GTAGAT-
GGTGGGCAGGAAGA-3′; amplicon size: 150 bp) were kindly provided
by Dr S. B. Geutskens (LUMC, Leiden, The Netherlands) and CXCL12
(Fw: 5′-CACATCTAACCTCATCTTC-3′; Rv: 5′-GACTTACTCTTCAC-
ATAGC-3′; amplicon size: 180 bp) primers were described in Costantini
et al. (2013). GAPDH was used as housekeeping gene (Fw: 5′-AATCCC-
ATCACCATGTTCCA-3′; Rv: 5′-TGGACTCCACGACGTACTCA-3′;
amplicon size: 160 bp) (van der Vaart et al., 2014).
Ca2+ flux assay
MDA-MB-231-B andMDA-MB-231 cells (5×104 to 1×105) were seeded in
uncoated µ-Dish35mm ibidi dishes (81156, ibidi) to adhere overnight.
Adherent cells forming a 50% confluent monolayer were pre-incubated for
30 min at 37°C with 1-10 µM cell permeant calcium sensor Fluo-4, AM
(F14217, Invitrogen). Cells were kept in Dulbecco’s phosphate buffered
saline (DPBS) until and during imaging. Ca2+ flux was measured upon
stimulation with recombinant human CXCL12-α (300-28A, Peprotech)
(100-300 nM), zebrafish CXCL12a (500 nM) or CXCL12b (100 nM)
ligands (Boldajipour et al., 2011) by fluorescent signal imaging, using an
Axiovert200 microscope (Zeiss, Germany) combined with a spinning disk
unit (CSU-X1, Yokogawa, Japan) and a CCD camera (iXon 897, Andor,
UK). Time-lapse imaging was performed using a 20× objective with a laser
illumination at 488 nm (Crystal), at a 200 ms or 1 s time interval. Image
analysis was performed using self-written algorithms in MatLab
(MathWorks Inc., USA).
Inoculum preparation for engraftment and xenotransplantation
Cell suspension was prepared once cells had grown to a 70-80% confluent
monolayer. After detachment with trypsin-EDTA (30-2101, ATCC®),
tumor cells were washed once in complete medium and twice in DPBS
(GIBCO® by Life Technologies). Centrifugation steps were performed for
5 min at 200 g (Eppendorf 5702). 2% PVP40 (polyvinylpyrrolidone-40)
was used for the final cell suspension. 2-day-old zebrafish embryos,
manually dechorionated and treated with 0.003% PTU (1-phenyl-2-
thiourea, Sigma-Aldrich) at 24 hpf, were anesthetized using 0.02%
Tricaine (MS-222) and transferred in a Petri dish with a 1.5% agarose
coating layer. Cell suspension was loaded in a glass capillary, prepared using
a Flaming/Brown micropipette puller (model P-97, Sutter Instrument Co.).
Forceps were used to cut the end of the needle and injection tests were
performed in a drop of water to set pressure and time parameters, in order to
engraft 300-500 cells. Tumor cells were inoculated in the blood circulation,
via the duct of Cuvier. Engrafted embryos were transferred to a new Petri
dish and kept at 34°C. Embryos were checked 3- to 5-h post implantation
(hpi) for correct engraftment and the ones showing tumor cells in the blood
circulation were selected for experiments.
Microscopy and phenotype assessment in vivo
Tumor burden of early metastases, extravasation and tissue invasion were
assessed via imaging of the tail fin region, in proximity of the CHT, at 2 and
4 dpi. In order to quantify tumor burden, single-embryo pictures were
acquired. Cell aggregates inside the blood vessels, as well as extravasating
and invading single cells, were included in the analysis of tumor burden and
comprehended in the definition of early metastases and micrometastases.
Tumor cell extravasation and invasion were also quantified separately from
intravascular tumor mass by counting the number of cells per embryo
and acquiring representative micrographs. A Leica MZ16FA fluorescent
microscope coupled to a DFC420C camera was used. GFP and dsRed
channels were overlaid in LAS AF Lite software and snapshots were
analyzed in Image-Pro Analyzer 7.0 (Media Cybernetics). For each larva,
tumor burden was calculated based on the number of objects multiplied by
mean area and mean intensity, generated with a macro designed by H. de
Bont (Toxicology, LACDR, Leiden University) and previously used to
quantify tumor migration and proliferation (Ghotra et al., 2012; van der Ent
et al., 2014b). In each micrograph, larvae are shown in lateral view and
oriented head (left)-to-tail (right), as shown by representative cartoons.
Chemokine injection, L-P staining and in silico analysis
Human CXCL12-α (0.4 mg/ml) (300-28A, Peprotech) or zebrafish
Cxcl11aa (1.5 mg/ml) (Torraca et al., 2015) chemokines, or water control
(1 nl), were injected in the hindbrain ventricle (HBV) of 30-32 hpf embryos.
Sample fixation was done at 3-3.5 hpi with 4% paraformaldehyde (PFA)
(O.N. at 4°C or for 3 h at room temperature). Macrophages were counted as
mpeg+ cells in the Tg(mpeg1:mCherry)UMSF001 line and L-plastin (L-P)+/
Tyramide Signal Amplification (TSA)− cells when immunohistochemistry
was performed, as described previously (Cui et al., 2011; Loynes et al.,
2010). Images were acquired using a Leica TCS SPE confocal microscope
with an HC PL FLUOTAR 10× DRY objective (0.30 N.A.). In each
micrograph, embryos are shown in lateral view and oriented head (left)-to-
tail (right) and injection site shown by schematic drawing. Human and
zebrafish CXCL12/Cxcl12 and CXCR4/Cxcr4 sequences were obtained in
UniProt (The UniProt Consortium, 2015) and aligned in ClustalW (Goujon
et al., 2010; Larkin et al., 2007). Specific domains of the human proteins for
ligand binding and receptor activation were reported in UniProt.
Statistical analysis
Unpaired, two-tailed t-test was used to compare the means of two groups
and Welch’s correction applied when variances were significantly different
(P<0.05). For datasets of three or more groups, one-way ANOVA with
Bonferroni post-hoc test was performed. Raw or normalized data are
mean±s.e.m. of pooled data points from at least two independent
experiments. Statistics were performed with GraphPad Prism 6.
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